Medicare fraud claims against Barton Associates fall short

In the federal First Circuit, Reynaldo Solano and Neals Maxilin lost their attempt to revive a whistleblower lawsuit against Barton Associates, Inc. The court said their complaint did not describe the alleged fraud with enough detail to meet the rules that apply to False Claims Act cases.

That matters for people who depend on Medicare and other government health programs because the ruling kept the case from moving into evidence gathering. The judges did not decide whether Barton actually ran a fraud scheme. They said the allegations were too thin to support the claim in court.

What the whistleblowers claimed

Solano and Maxilin brought the case as a qui tam action, a type of whistleblower lawsuit that lets private plaintiffs sue on the government’s behalf. They said Barton, a staffing company that places medical professionals in temporary jobs, helped set up a process that led to false claims being submitted to Medicare and other government benefit programs.

According to the complaint, Barton encouraged clients to create call centers, sent patients to Barton physicians, and collected an added assessment fee for each prescription those physicians wrote. The complaint also said several companies, including Medtech Worldwide, RealTime Physicians, Ocenture and CareLumina, used Barton doctors to generate prescriptions for tests, equipment and medications that were then billed to the government.

Why the court said the case came up short

The court focused on Federal Rule of Civil Procedure 9(b), which requires fraud claims to be pleaded with particular detail. In plain terms, a plaintiff has to do more than describe a suspicious setup. The complaint must give a clear picture of who did what, when, where and how the alleged fraud worked.

The judges said Solano and Maxilin did not provide enough specifics about the supposed false claims themselves. They pointed to missing details about timing, locations, amounts and the government programs involved. They also said the complaint did not connect the alleged scheme closely enough to actual claims submitted for payment.

The First Circuit also upheld the lower court’s refusal to reopen the case or let the whistleblowers revise their complaint. The result leaves the allegations unresolved and unproven, but it underscores how often False Claims Act cases turn on the strength of the pleading before they ever reach the merits.

The bigger takeaway

False Claims Act cases can be powerful tools against healthcare fraud, but they face a high bar at the start. Courts want enough detail to show that a real fraud claim is being made, not just a theory that something improper may have happened.

Here, the judges said that bar was not met. For Barton Associates, that meant the case stayed dismissed. For whistleblowers and public health programs, it is another reminder that a detailed complaint can be just as important as the underlying accusation.